Abstract
ABSTRACT: Dopamine is frequently used in neonatal intensive care for its vasopressor, renal vasodilating, and cardiac inotropic properties. The effect of i.v. dopamine infusion on neonatal pituitary hormone secretion is currently unknown. We observed strikingly low serum concentrations of growth hormone (GH) and prolactin (PRL) during a therapeutic, standardized, isovolumctric, partial exchange transfusion (blood sampling every 20 min for 6 h) in two polycythemic neonates requiring intensive therapy, including continuous dopamine infusion. In addition, the secretion of GH and PRL was studied in three neonates with symptomatic polycythemia (gestational age 34–38 wk; birth weight 2110–2530 g; postnatal age 10–30 h) during a partial exchange transfusion, including an intervening dopamine infusion (8 μg/kg/min i.v. for 2 h). The GH and PRL profiles were evaluated by deconvolution analysis. Initially, the three newborns exhibited high-amplitude, pulsatile GH secretion and continuously elevated PRL release. During the dopamine infusion, GH secretion was virtually abolished and PRL release was reduced by at least 50%. Dopaminc withdrawal was associated with a rebound release of GH and PRL. Finally, scrum GH and PRL concentrations were studied in nine nonpolycythemic newborns (gestational age 31–40 wk; birth weight 1680–4000 g; postnatal age 2–28 d) at the end of a prolonged dopamine infusion (3–5 μg/kg/min i.v. for 2–27 d). Within 2 h after dopamine withdrawal, GH and PRL levels increased a median 3-fold and 10-fold respectively. These data concord to indicate that dopaminc is a potent inhibitor of GH and PRL secretion in the human newborn.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zegher, F., Den Berghe, G., Devlieger, H. et al. Dopamine Inhibits Growth Hormone and Prolactin Secretion in the Human Newborn. Pediatr Res 34, 642–645 (1993). https://doi.org/10.1203/00006450-199311000-00016
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199311000-00016
This article is cited by
-
Pubertal timing in adolescents with ADHD: extension and replication in an all-female sample
European Child & Adolescent Psychiatry (2023)
-
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
CNS Drugs (2018)
-
The relationship between serum levels of prolactin and growth hormone in the early postnatal period
Pediatric Research (2017)
-
Treating hypotension in the preterm infant: when and with what: a critical and systematic review
Journal of Perinatology (2007)
-
Effekte von Dopamin auf die zelluläre und humorale Immunantwort von Patienten mit Sepsis
Der Anaesthesist (2005)